Pier Francesco Rambaldi: Whole-body FDG PET Imaging in Oncology—Clinical Reports
نویسندگان
چکیده
منابع مشابه
[Visualization of normal organs in whole-body FDG-PET imaging].
It is important to know FDG accumulation in the normal distributions for interpreting whole-body PET imaging for tumor detection. Twenty-eight normal subjects were studied with whole-body PET imaging and were examined the intensity of FDG uptake in major organs and the factors which caused it's variety. Emission images were acquired and images were reconstructed without attenuation correction. ...
متن کاملOptimized dose regimen for whole-body FDG-PET imaging
BACKGROUND The European Association of Nuclear Medicine procedure guidelines for whole-body fluorodeoxyglucose positron-emission tomography (FDG-PET) scanning prescribe a dose proportional to the patient's body mass. However, clinical practice shows degraded image quality in obese patients indicating that using an FDG dose proportional to body mass does not overcome size-related degradation of ...
متن کاملWhole-Body FDG-PET and PET/CT Imaging in Ovarian Cancer
Dr. Hubner has no significant financial arrangement or affiliation with any manufacturer of any pharmaceutical or medical device and is not affiliated in any manner with any provider of any commercial medical or healthcare professional service. O varian cancer afflicts 25,000 women in the U.S. every year, and this aggressive cancer caused about 14,000 deaths last year. Because of the extremely ...
متن کاملImplementation of quadratic dose protocol for 18F-FDG whole-body PET imaging using a BGO-based PET/CT scanner, GE Discovery ST
Introduction: The ability of quadratic dose protocol to maintain a good quality image for an overweight and obese patient is well reported. However, a practical approach to the implementation of this protocol in whole-body imaging in Malaysia is currently lacking. Hence, the aim of this study is to derive the quadratic dose formula that suits our PET system. Metho...
متن کاملWhole-body imaging with PET/MRI.
Whole-body positron emission tomography (PET) scanning with the radiolabeled glucose analogue 2-[fluorine-18]-fluoro-2-deoxy-D-glucose ( superset 18 F-FDG) can identify areas of cancerous involvement and distinguish malignant from benign lesions and therefore, plays an important role in the diagnosis and management of patients with cancer. PET facilitates the evaluation of metabolic and molecul...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Nuclear Medicine and Molecular Imaging
سال: 2014
ISSN: 1619-7070,1619-7089
DOI: 10.1007/s00259-014-2878-4